Prescription norepinephrine-dopamine reuptake inhibitor (NDRI) approved for major depressive disorder, seasonal affective disorder, and smoking cessation (marketed as Zyban). Unique among antidepressants for its lack of significant sexual side effects and weight-neutral to weight-loss profile. Also used off-label for ADHD. Carries a dose-dependent seizure risk. Dosage must be determined by your prescribing physician.
Current or prior diagnosis of bulimia or anorexia nervosa
The bottom line
Evidence rating strong. Most-documented uses: depression symptom relief, no sexual side effects, smoking cessation aid. 10 sources indexed (2018–2024), with 2 interaction records on file.
The science
How it works, mechanistically.
Core mechanism
Inhibits the reuptake of norepinephrine (NE) and dopamine (DA) by blocking the norepinephrine transporter (NET) and dopamine transporter (DAT). Does not significantly affect serotonin reuptake, which accounts for its distinct side effect profile. Also acts as a nicotinic acetylcholine receptor antagonist, contributing to its efficacy for smoking cessation.10
Class
Atypical Antidepressant (NDRI)
Dosing
Dosing & protocol.
Common range
150–450 mg daily (as prescribed by your physician)
Recommended form
Sustained-release or extended-release tablet
Can be taken with or without food. Do not crush, chew, or divide sustained/extended-release tablets. Space doses at least 8 hours apart for SR formulation.
Both bupropion and St. John's Wort lower the seizure threshold, and combining them may significantly increase seizure risk. Bupropion already carries a dose-dependent seizure warning, and St. John's Wort's effects on multiple neurotransmitter systems compound this risk.
Recommendation: Avoid combining St. John's Wort with bupropion due to increased seizure risk. If mood support beyond bupropion is needed, discuss evidence-based augmentation strategies with your prescriber.
Bupropion and nicotine replacement have been intentionally combined for smoking cessation, and the combination can improve quit rates for some people. The same combination can also increase insomnia, headache, jitteriness, palpitations, and blood pressure concerns, especially if nicotine is used heavily through vaping, pouches, or multiple replacement products. Bupropion also lowers seizure threshold, so excess stimulant-like exposure matters.
Recommendation: Use nicotine with bupropion only as part of a planned cessation strategy or with your clinician's knowledge. Check blood pressure and pulse if you use nicotine frequently or develop headaches, palpitations, anxiety, or chest tightness. Seek urgent care for chest pain, fainting, severe shortness of breath, seizure, or a new irregular heartbeat.
Ji M, Feng J, Liu G. Efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression or major depressive disorder: A systematic review and meta-analysis of randomized controlled trials. PloS one. 2024
Bakouni H, Sharafi H, Bahremand A et al.. Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials. Drug and alcohol dependence. 2023
Akbar D, Rhee TG, Ceban F et al.. Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials. CNS drugs. 2023
Sposito AC, Bonilha I, Luchiari B et al.. Cardiovascular safety of naltrexone and bupropion therapy: Systematic review and meta-analyses. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2021
Network meta-analysis of adult ADHD treatments found bupropion significantly reduced ADHD symptoms compared to placebo, with efficacy comparable to atomoxetine and guanfacine but lower than stimulants.
Turner E, Jones M, Vaz LR et al.. Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2019
Network meta-analysis of 133 RCTs found bupropion effective for ADHD symptoms across all age groups, though less efficacious than stimulants (methylphenidate, amphetamines); bupropion was among the best-tolerated non-stimulant options.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Bupropion in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack